Can overuse and the availability of antibiotics without doctor's prescription, be the contributors to the emergence of drug-resistant diseases in India? What are the available mechanisms for monitoring and control? Critically discuss the various issues involved.

Introduction

The overuse and unregulated availability of antibiotics have been identified as major contributors to the rise of antimicrobial resistance (AMR) globally. In India, the problem is particularly acute, with the country being the largest consumer of antibiotics in the world (Lancet, 2021). The emergence of drug-resistant diseases poses a significant threat to public health, economic stability, and the effectiveness of modern medicine.

Key Dimensions of Antibiotic Overuse and Resistance in India

Overuse and Availability of Antibiotics: Contributors to Drug Resistance

1. Overuse of Antibiotics

• Self-medication: Easy access to antibiotics without prescriptions leads to indiscriminate use, often for viral infections where they are ineffective.
  • Example: Over-the-counter sale of antibiotics like azithromycin during the COVID-19 pandemic.
• Inappropriate prescriptions: Doctors often prescribe broad-spectrum antibiotics unnecessarily, contributing to resistance.
  • Data: A study by the Indian Journal of Pharmacology (2020) found that 50% of antibiotic prescriptions in India were inappropriate.

2. Unregulated Availability

• Over-the-counter sales: Pharmacies often sell antibiotics without prescriptions, violating the Drugs and Cosmetics Act, 1940.
• Online pharmacies: The rise of e-pharmacies has further exacerbated the problem, with limited regulatory oversight.

3. Agricultural Misuse

• Use in livestock: Antibiotics are widely used as growth promoters in poultry and aquaculture, leading to the development of resistant bacteria.
  • Fact: India is the fourth-largest consumer of antibiotics in animal food production (FAO, 2021).

4. Lack of Awareness

• Public ignorance: Many individuals are unaware of the risks of incomplete antibiotic courses or misuse.
• Healthcare gaps: Limited training on AMR for healthcare professionals in rural areas.

Mechanisms for Monitoring and Control

1. National Action Plan on AMR (2017-2021)

• Aims to strengthen surveillance, regulate antibiotic use, and promote awareness.
• Limitation: Implementation remains weak due to lack of funding and coordination.

2. Red Line Campaign

• Introduced by the Ministry of Health to label prescription-only antibiotics with a red line to discourage over-the-counter sales.
• Challenge: Poor enforcement and limited public awareness.

3. Integrated Disease Surveillance Programme (IDSP)

• Monitors AMR trends across the country.
• Issue: Limited coverage and inadequate infrastructure in rural areas.

4. Regulation of Antibiotics in Agriculture

• The Food Safety and Standards Authority of India (FSSAI) has issued guidelines to curb antibiotic use in food production.
• Gap: Enforcement remains weak, and monitoring mechanisms are underdeveloped.

Issues Involved in Addressing AMR

1. Weak Regulatory Framework

• Poor enforcement of existing laws like the Drugs and Cosmetics Act.
• Lack of stringent penalties for violations by pharmacies and online platforms.

2. Healthcare Infrastructure Deficits

• Inadequate diagnostic facilities to identify bacterial infections, leading to empirical antibiotic use.
• Limited access to affordable healthcare drives self-medication.

3. Economic and Social Factors

• High out-of-pocket expenditure on healthcare compels people to seek cheaper, unregulated options.
• Misuse of antibiotics in agriculture is driven by economic incentives for higher yields.

4. Global Linkages

• India’s role as a major exporter of generic antibiotics contributes to the global spread of AMR.
• Cross-border transmission of resistant pathogens due to international travel and trade.

Way Forward

1. Strengthening Regulations

• Enforce stricter penalties for over-the-counter sales of antibiotics.
• Regulate online pharmacies through a robust digital monitoring framework.

2. Improving Healthcare Infrastructure

• Expand diagnostic facilities to enable targeted antibiotic use.
• Train healthcare professionals on AMR, especially in rural areas.

3. Public Awareness Campaigns

• Scale up initiatives like the Red Line Campaign with community-level outreach.
• Integrate AMR education into school curricula.

4. Global Collaboration

• Participate actively in global initiatives like the Global Antimicrobial Resistance and Use Surveillance System (GLASS).
• Promote research and development of new antibiotics through public-private partnerships.

Conclusion

The overuse and unregulated availability of antibiotics are indeed significant contributors to the emergence of drug-resistant diseases in India. Addressing this challenge requires a multi-pronged approach involving stricter regulations, improved healthcare infrastructure, public awareness, and global collaboration. By aligning with SDG 3 (Good Health and Well-being), India can mitigate the AMR crisis and safeguard public health for future generations.